NCT07234123

Brief Summary

This "pain reduces pain" study looks at how the brain reduces pain when a person feels two painful sensations at the same time. There is considerable evidence that the brain can "turn down" pain using natural endogenous pain-control systems. The current CPM study measures whether attentional processes can also make a measurable contribution to pain inhibition alongside neurochemical mechanisms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 9, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2025

Completed
Last Updated

January 7, 2026

Status Verified

January 1, 2026

Enrollment Period

10 months

First QC Date

November 14, 2025

Last Update Submit

January 2, 2026

Conditions

Keywords

Conditioned Pain Modulation

Outcome Measures

Primary Outcomes (2)

  • worst pain ratings of foot only

    graphic rating scale from 0 (no pain) to 10 (excruciating pain)

    rated immediately after each thermal stimulus

  • worst pain on graphic rating scale during test+conditioning stimulus

    graphic rating scale from 0 (no pain) to 10 (excruciating pain)

    measured immediately after the stimuli

Secondary Outcomes (4)

  • % of attention devoted to foot during test stimulus only (0-100% scale)

    rated immediately after the stimuli

  • % of attention devoted to foot during test+conditioning stimuli (0-100% scale)

    rated immediately after the thermal stimuli

  • Divided attention during test stimulus only (% correct, where 100% is highest accuracy)

    Day 1, during the thermal stimulus

  • Divided attention during test stimulus + conditioning stimulus (% correct, 100% is highest )

    Day 1, during the thermal stimuli

Other Outcomes (4)

  • distraction difficulty during test stimulus only (0 to 10 scale, where 10 is most distracting)

    immediately after the phase 1 thermal stimuli

  • distraction difficult during simultaneous test + conditioning stimuli (graphic rating scale)

    Exploratory: immediately after the phase 1 thermal stimuli

  • difficulty concentrating during test stimulus only (0 to 10 scale, 10 = most difficult concentr

    Exploratory: immediately after the phase 1 thermal stimuli

  • +1 more other outcomes

Study Arms (2)

Single pain stimulus

EXPERIMENTAL

test pain stimulus alone

Behavioral: test stimulus

dual pain stimuli

EXPERIMENTAL

simultaneous foot (test stimulus + wrist (conditioning stimulus)

Behavioral: conditioned pain modulation

Interventions

simultaneous stimuli to foot (test stimulus) and wrist (conditioning stimulus)

dual pain stimuli
test stimulusBEHAVIORAL

single brief stimulus to foot only

Single pain stimulus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Only University of Washington students in eligible psychological courses are
  • eligible. General public is not eligible.
  • Enrolled psychology students fluent in English,
  • Age ≥18 y, able to follow instructions.

You may not qualify if:

  • Seizure history,
  • Migraines,
  • Diabetes,
  • Extreme pain insensitivity,
  • Motion sickness,
  • or prior participation in this protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington Seattle

Seattle, Washington, 98195, United States

Location

Related Publications (1)

  • Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010 Oct;23(5):611-5. doi: 10.1097/ACO.0b013e32833c348b.

    PMID: 20543676BACKGROUND

Study Officials

  • Hunter Hoffman

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: within-subject design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 18, 2025

Study Start

August 9, 2024

Primary Completion

May 29, 2025

Study Completion

May 29, 2025

Last Updated

January 7, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Summary statistics will be made available to researchers upon reasonable request (e.g, for meta-analyses, etc). No individually identifiable information will be made available.

Time Frame
The de-identified summary data will be available from time of publication for at least five years after publication.
Access Criteria
The de-identified summary data will be e-mailed to researchers upon reasonable request

Locations